CARM · Categories · Form 4
CARM - SEC Form 4 insider transactions
Carisma Therapeutics Inc. (CARM) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CARM
- Chief Scientific Officer Klichinsky Michael exercised 56,982 shares at a strike of $0.11 and sold $14,485 worth of shares (56,982 units at $0.25) (SEC Form 4)4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- Chief Scientific Officer Klichinsky Michael sold $124,343 worth of shares (484,347 units at $0.26), closing all direct ownership in the company (SEC Form 4)4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Klichinsky Michael4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by President and CEO Kelly Steven4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Cheng Sohanya Roshan4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Thorell Marella4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Scadden David4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Zweifach Sanford S4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Morrison Briggs4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Hohneker John4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Director Torok Michael4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Morris Richard Steven4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Chief Scientific Officer Klichinsky Michael4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by President and CEO Kelly Steven4 - Carisma Therapeutics Inc. (0001485003) (Issuer)
- SEC Form 4 filed by Hohneker John4 - Carisma Therapeutics Inc. (0001485003) (Issuer)